Involvement of the Opioid Peptide Family in Cancer Progression
Peptides mediate cancer progression favoring the mitogenesis, migration, and invasion of tumor cells, promoting metastasis and anti-apoptotic mechanisms, and facilitating angiogenesis/lymphangiogenesis. Tumor cells overexpress peptide receptors, crucial targets for developing specific treatments aga...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2023-07-01
|
| Series: | Biomedicines |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2227-9059/11/7/1993 |
| _version_ | 1797590180379492352 |
|---|---|
| author | Manuel Lisardo Sánchez Francisco D. Rodríguez Rafael Coveñas |
| author_facet | Manuel Lisardo Sánchez Francisco D. Rodríguez Rafael Coveñas |
| author_sort | Manuel Lisardo Sánchez |
| collection | DOAJ |
| description | Peptides mediate cancer progression favoring the mitogenesis, migration, and invasion of tumor cells, promoting metastasis and anti-apoptotic mechanisms, and facilitating angiogenesis/lymphangiogenesis. Tumor cells overexpress peptide receptors, crucial targets for developing specific treatments against cancer cells using peptide receptor antagonists and promoting apoptosis in tumor cells. Opioids exert an antitumoral effect, whereas others promote tumor growth and metastasis. This review updates the findings regarding the involvement of opioid peptides (enkephalins, endorphins, and dynorphins) in cancer development. Anticancer therapeutic strategies targeting the opioid peptidergic system and the main research lines to be developed regarding the topic reviewed are suggested. There is much to investigate about opioid peptides and cancer: basic information is scarce, incomplete, or absent in many tumors. This knowledge is crucial since promising anticancer strategies could be developed alone or in combination therapies with chemotherapy/radiotherapy. |
| first_indexed | 2024-03-11T01:16:50Z |
| format | Article |
| id | doaj.art-9e815eea53a6420b8004e726452ce4c2 |
| institution | Directory Open Access Journal |
| issn | 2227-9059 |
| language | English |
| last_indexed | 2024-03-11T01:16:50Z |
| publishDate | 2023-07-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Biomedicines |
| spelling | doaj.art-9e815eea53a6420b8004e726452ce4c22023-11-18T18:27:55ZengMDPI AGBiomedicines2227-90592023-07-01117199310.3390/biomedicines11071993Involvement of the Opioid Peptide Family in Cancer ProgressionManuel Lisardo Sánchez0Francisco D. Rodríguez1Rafael Coveñas2Laboratory of Neuroanatomy of the Peptidergic Systems, Institute of Neurosciences of Castilla and León (INCYL), University of Salamanca, 37007 Salamanca, SpainDepartment of Biochemistry and Molecular Biology, Faculty of Chemical Sciences, University of Salamanca, 37007 Salamanca, SpainLaboratory of Neuroanatomy of the Peptidergic Systems, Institute of Neurosciences of Castilla and León (INCYL), University of Salamanca, 37007 Salamanca, SpainPeptides mediate cancer progression favoring the mitogenesis, migration, and invasion of tumor cells, promoting metastasis and anti-apoptotic mechanisms, and facilitating angiogenesis/lymphangiogenesis. Tumor cells overexpress peptide receptors, crucial targets for developing specific treatments against cancer cells using peptide receptor antagonists and promoting apoptosis in tumor cells. Opioids exert an antitumoral effect, whereas others promote tumor growth and metastasis. This review updates the findings regarding the involvement of opioid peptides (enkephalins, endorphins, and dynorphins) in cancer development. Anticancer therapeutic strategies targeting the opioid peptidergic system and the main research lines to be developed regarding the topic reviewed are suggested. There is much to investigate about opioid peptides and cancer: basic information is scarce, incomplete, or absent in many tumors. This knowledge is crucial since promising anticancer strategies could be developed alone or in combination therapies with chemotherapy/radiotherapy.https://www.mdpi.com/2227-9059/11/7/1993enkephalinendorphindynorphinopioid receptorapoptosismetastasis |
| spellingShingle | Manuel Lisardo Sánchez Francisco D. Rodríguez Rafael Coveñas Involvement of the Opioid Peptide Family in Cancer Progression Biomedicines enkephalin endorphin dynorphin opioid receptor apoptosis metastasis |
| title | Involvement of the Opioid Peptide Family in Cancer Progression |
| title_full | Involvement of the Opioid Peptide Family in Cancer Progression |
| title_fullStr | Involvement of the Opioid Peptide Family in Cancer Progression |
| title_full_unstemmed | Involvement of the Opioid Peptide Family in Cancer Progression |
| title_short | Involvement of the Opioid Peptide Family in Cancer Progression |
| title_sort | involvement of the opioid peptide family in cancer progression |
| topic | enkephalin endorphin dynorphin opioid receptor apoptosis metastasis |
| url | https://www.mdpi.com/2227-9059/11/7/1993 |
| work_keys_str_mv | AT manuellisardosanchez involvementoftheopioidpeptidefamilyincancerprogression AT franciscodrodriguez involvementoftheopioidpeptidefamilyincancerprogression AT rafaelcovenas involvementoftheopioidpeptidefamilyincancerprogression |